Department of Otorhinolaryngology Head - Neck Surgery, Kyung Hee University School of Medicine, Kyung Hee University Medical Center, Seoul, Korea.
Center for Digital Health, Medical Science Research Institute, Kyung Hee University School of Medicine, Kyung Hee University Medical Center, Seoul, Korea.
J Int Adv Otol. 2023 Jun;19(3):228-233. doi: 10.5152/iao.2023.22937.
Side effects occurring after COVID-19 vaccination can include vertigo and dizziness. Despite its high incidence, few studies to date have assessed dizziness/vertigo after vaccination. The present study investigated the incidence of dizziness/vertigo after COVID-19 vaccination in South Korea.
Adverse reactions to COVID-19 vaccination reported to the Korea Disease Control and Prevention Agency from February 26, 2021, to July 31, 2022 (week 74) were analyzed. The incidence rates of dizziness/vertigo in subjects vaccinated with 5 COVID-19 vaccines, AZD1222 (AstraZeneca), BNT162b2 (Pfizer-BioNTech), JNJ-78436735 (Janssen), mRNA-1273 (Moderna), and NVX-CoV2373 (Novavax), were determined.
A total of 126 725 952 doses of COVID-19 vaccine were administered, with 473 755 suspected adverse reactions (374 per 100 000 vaccinations) reported. Vertigo/dizziness was reported after the administration of 68 759 doses, or 54.3 per 100 000 vaccinations, making it the third most common adverse reaction after headache and muscle pain.
Dizziness/vertigo was generally a mild adverse reaction after COVID-19 vaccination, but it was the third most common adverse reaction in Korea. Studies are necessary to clarify the causal relationship between vaccination and dizziness/vertigo and to prepare subjects for this possible adverse reaction.
新冠病毒疫苗接种后可能出现眩晕和头晕等副作用。尽管其发病率很高,但迄今为止,很少有研究评估接种疫苗后的头晕/眩晕。本研究调查了韩国新冠病毒疫苗接种后头晕/眩晕的发生率。
分析了 2021 年 2 月 26 日至 2022 年 7 月 31 日(第 74 周)向韩国疾病控制和预防机构报告的新冠病毒疫苗接种不良反应。确定了接种 5 种新冠病毒疫苗(阿斯利康的 AZD1222、辉瑞-生物科技的 BNT162b2、强生的 JNJ-78436735、莫德纳的 mRNA-1273 和诺瓦瓦克斯的 NVX-CoV2373)的受试者中头晕/眩晕的发生率。
共接种了 126725952 剂新冠病毒疫苗,报告了 473755 例疑似不良反应(每 100000 剂接种 374 例)。在接种 68759 剂后报告了眩晕/头晕,或每 100000 剂接种 54.3 例,是继头痛和肌肉疼痛之后第三常见的不良反应。
头晕/眩晕通常是新冠病毒疫苗接种后的轻度不良反应,但在韩国是第三常见的不良反应。有必要进行研究以明确接种疫苗与头晕/眩晕之间的因果关系,并使受种者对此可能的不良反应有所准备。